Common Stock, Shares, Outstanding of Sonnet BioTherapeutics Holdings, Inc. from Q4 2010 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q2 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 3.33M shares, a 36.1% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 3.33M -1.89M -36.1% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 3.12M +11K +0.35% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 3.01M -62.1K -2.02% 31 Dec 2024 10-Q 13 Feb 2025
Q3 2024 650K +431K +197% 30 Sep 2024 10-Q 13 Aug 2025
Q2 2024 5.22M -33.2M -86.4% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 3.11M -17.4M -84.8% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 3.07M -4.89M -61.5% 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 219K -33.2K -13.2% 30 Sep 2023 10-K 17 Dec 2024
Q2 2023 38.4M -22.2M -36.6% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 20.5M -39.8M -66% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 7.96M -52.3M -86.8% 31 Dec 2022 10-Q 13 Feb 2023
Q3 2022 252K -4.05M -94.1% 30 Sep 2022 10-K 14 Dec 2023
Q2 2022 60.6M +35.8M +145% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 60.3M +39.1M +184% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 60.3M +43.1M +251% 31 Dec 2021 10-Q 08 Feb 2022
Q3 2021 4.3M -10.4M -70.8% 30 Sep 2021 10-K 15 Dec 2022
Q2 2021 24.8M +15.6M +169% 30 Jun 2021 10-Q 16 Aug 2021
Q1 2021 21.2M +20.6M +3759% 31 Mar 2021 10-Q 17 May 2021
Q4 2020 17.2M +16.8M +4192% 31 Dec 2020 10-Q 16 Feb 2021
Q3 2020 14.7M +9.18M +165% 30 Sep 2020 10-K 17 Dec 2021
Q2 2020 9.2M +2.19M +31.2% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 549K -3.18M -85.3% 31 Mar 2020 10-Q 18 May 2020
Q4 2019 400K -3.32M -89.2% 31 Dec 2019 10-Q 18 May 2020
Q3 2019 5.55M +1.84M +49.7% 30 Sep 2019 10-K 17 Dec 2020
Q2 2019 7.01M +3.31M +89.6% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 3.73M +510K +15.8% 31 Mar 2019 10-Q 15 May 2019
Q4 2018 3.72M +670K +22% 31 Dec 2018 10-K 19 Mar 2020
Q3 2018 3.71M +1.19M +47.4% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 3.7M +1.2M +47.9% 30 Jun 2018 10-Q 13 Aug 2018
Q1 2018 3.22M -18.9M -85.5% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 3.05M +906K +42.4% 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 2.51M -19.4M -88.6% 30 Sep 2017 10-Q 13 Nov 2017
Q2 2017 2.5M -19.5M -88.6% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 22.1M +812K +3.81% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 2.14M -19.2M -90% 31 Dec 2016 10-K 30 Mar 2018
Q3 2016 22M +628K +2.95% 30 Sep 2016 10-Q 10 Nov 2016
Q2 2016 22M +8.28M +60.5% 30 Jun 2016 10-Q 11 Aug 2016
Q1 2016 21.3M +9.03M +73.4% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 21.3M +14.1M +194% 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 21.3M +14.4M +206% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 13.7M +7.18M +111% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 12.3M +5.98M +94.7% 31 Mar 2015 10-Q 20 May 2015
Q4 2014 7.25M +1.86M +34.6% 31 Dec 2014 10-K 31 Mar 2016
Q3 2014 6.98M +2.51M +56.2% 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 6.5M +2.8M +75.5% 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 6.32M +2.62M +70.9% 31 Mar 2014 10-Q 15 May 2014
Q4 2013 5.39M +1.69M +45.7% 31 Dec 2013 10-K 15 Apr 2015
Q3 2013 4.47M +769K +20.8% 30 Sep 2013 10-Q 15 Nov 2013
Q2 2013 3.7M +4K +0.11% 30 Jun 2013 10-Q 12 Aug 2013
Q1 2013 3.7M +1.2M +48% 31 Mar 2013 10-Q 15 May 2013
Q4 2012 3.7M +2.45M +196% 31 Dec 2012 10-K 31 Mar 2014
Q3 2012 3.7M +1.2M +48% 30 Sep 2012 10-Q/A 31 Dec 2012
Q2 2012 3.7M +1.24M +50.3% 30 Jun 2012 10-Q/A 02 Jan 2013
Q1 2012 2.5M 31 Mar 2012 10-Q/A 28 Dec 2012
Q4 2011 1.25M -799K -39% 31 Dec 2011 10-K 03 Apr 2013
Q3 2011 2.5M 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 2.46M 30 Jun 2011 10-Q 15 Aug 2011
Q4 2010 2.05M 31 Dec 2010 10-K/A 28 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.